Colfax Corporation (NYSE:CFX) has a beta of 2.21, a 12-month trailing P/E ratio of 88.69, and a growth ratio of 4.11. The stock’s Relative Strength Index (RSI) is 59.64, with weekly volatility at 1.87% and ATR at 1.07. The CFX stock’s 52-week price range has touched low of $24.70 and a $50.26 high. Its shares traded lower over the last trading session, losing -0.29% on 06/02/21. The shares fell to a low of $44.88 before closing at $45.23. Intraday shares traded counted 1.26 million, which was 21.25% higher than its 30-day average trading volume of 1.60M. CFX’s previous close was $45.36 while the outstanding shares total 139.60M.
Investors have identified the Specialty Industrial Machinery company Colfax Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $6.18 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Colfax Corporation (CFX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For CFX, the company has in raw cash 763.65 million on their books with 727.37 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 2.08 billion total, with 1.56 billion as their total liabilities.
CFX were able to record 59.84 million as free cash flow during the 08/11/2021 quarter of the year, this saw their quarterly net cash flow reduce by 662.58 million. In cash movements, the company had a total of 84.38 million as operating cash flow.
Potential earnings growth for Colfax Corporation (CFX)
In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the 08/11/2021 quarter of the year, Colfax Corporation recorded a total of 879.21 million in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 7.15% coming in sequential stages and their sales for the 08/11/2021 quarter increasing by 5.81%.
What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 508.13 million trying to sell their products during the last quarter, with the result yielding a gross income of 371.08 million. This allows shareholders to hold on to 139.60M with the recently reported earning now reading 0.13 cents per share. This is a figure that compared to analyst’s prediction for their 08/11/2021 (0.44 cents a share).
Having a look at the company’s valuation, the company is expected to record 2.48 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CFX sounds very interesting.
Is the stock of CFX attractive?
In related news, President & CEO, Trerotola Matthew L. sold 200,000 shares of the company’s stock in a transaction that recorded on May 14. The sale was performed at an average price of 43.14, for a total value of 8,628,400. As the sale deal closes, the SVP, Chief HR Officer, Lang Patricia A now sold 24,677 shares of the company’s stock, valued at 1,084,307. Also, EVP, Strategy & Business Dev., PRYOR DANIEL A sold 36,062 shares of the company’s stock in a deal that was recorded on Mar 10. The shares were price at an average price of 47.73 per share, with a total market value of 1,721,290. Following this completion of acquisition, the ESAB President and EVP, Colfax, Kambeyanda Shyam now holds 11,897 shares of the company’s stock, valued at 556,066. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.50%.
12 out of 18 analysts covering the stock have rated it a Buy, while 3 have maintained a Hold recommendation on Colfax Corporation. 2 analysts has assigned a Sell rating on the CFX stock. The 12-month mean consensus price target for the company’s shares has been set at $52.36.